telbivudine has been researched along with Hepatitis C, Chronic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forde, KA; Kaplan, DE; Serper, M | 1 |
| Ayana, DA; Cai, Y; Ji, H; Jiang, Y; Li, C; Liu, M; Lv, P | 1 |
| Berkley, EM; Dunkelberg, JC; Leslie, KK; Thiel, KW | 1 |
| Dusheiko, GM; Jacobs, MG | 1 |
1 review(s) available for telbivudine and Hepatitis C, Chronic
| Article | Year |
|---|---|
Hepatitis B and C in pregnancy: a review and recommendations for care.
Topics: Antiviral Agents; Breast Feeding; Cesarean Section; Contraindications; DNA, Viral; Female; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Mass Screening; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Telbivudine; Thymidine; Viremia | 2014 |
3 other study(ies) available for telbivudine and Hepatitis C, Chronic
| Article | Year |
|---|---|
Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort.
Topics: Aged; Alanine Transaminase; Antiviral Agents; Cohort Studies; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B virus; Hepatitis C; Hepatitis C, Chronic; Humans; Liver; Male; Middle Aged; Telbivudine; Tenofovir; United States; Veterans; Virus Activation | 2018 |
Serum interleukin-37 concentrations and HBeAg seroconversion in chronic HBV patients during telbivudine treatment.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Coinfection; Female; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Interleukin-1; Interleukin-10; Interleukin-2; Male; Middle Aged; Telbivudine; Thymidine; Young Adult | 2013 |
Perspectives on the management of chronic hepatitis B and C.
Topics: Antiviral Agents; Enzyme Inhibitors; Hepacivirus; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunoglobulins; Interferons; Mental Disorders; Nucleosides; Pyrimidinones; Substance-Related Disorders; Telbivudine; Thymidine | 2009 |